Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

Citation:
Faulk KE, Kairalla JA, Hibbitts E, …….. Kotecha RS, Guest E. Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1. Blood Adv. 2026;10(1):70-4.

Keywords:
Asparaginase; acute lymphoblastic leukemia; allergy; 
anaphylaxis; brain disease; drug safety; febrile neutropenia; hyperbilirubinemia; hypertriglyceridemial; liver failure; major clinical study; sepsis